Literature DB >> 15623692

Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease.

L Canafoglia1, C Ciano, F Panzica, V Scaioli, C Zucca, P Agazzi, E Visani, G Avanzini, S Franceschetti.   

Abstract

OBJECTIVE: To investigate whether Unverricht-Lundborg disease (ULD) and Lafora body disease (LBD) can be differentiated on the basis of their neurophysiologic profiles.
METHODS: Somatosensory evoked potentials (SSEPs), long-loop reflexes (LLRs), and the influence of conditioning nerve stimulation on the motor potentials evoked by transcranial stimulation in 8 patients with LBD and 10 patients with ULD were investigated.
RESULTS: Both groups showed sensorimotor cortex hyperexcitability, but their electrophysiologic profiles were different. Enlarged P25 to N33 SSEP components and enhanced LLRs were common in the ULD patients, whereas medium-latency "giant" SSEP components and less consistently enhanced LLRs were more frequently found in the patients with LBD. Cortical relay time was extremely brief in ULD but varied in LBD. Conditioning somatosensory stimuli differently affected motor cortex excitability, leading to early facilitation in ULD and delayed and prolonged facilitation in LBD.
CONCLUSIONS: Patients with Unverricht-Lundborg disease (ULD) and Lafora body disease (LBD) have different electrophysiologic profiles. The ULD findings point to an aberrant subcortical or cortical loop (possibly short-cutting the somatosensory cortex) that is involved in generating the prominent action myoclonus characterizing the disorder. The LBD findings highlight sustained hyperexcitability of the sensorimotor cortex in response to afferent stimuli, which fit with a more severe impairment of inhibitory mechanisms.

Entities:  

Mesh:

Year:  2004        PMID: 15623692     DOI: 10.1212/01.wnl.0000147475.71345.aa

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

2.  Progressive myoclonic ataxia with intrathecal immune activation in six patients.

Authors:  D Testa; E Ambrosoni; S Franceschetti; A Salmaggi; P Soliveri; F Girotti
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

3.  Sensorimotor, visual, and auditory cortical atrophy in Unverricht-Lundborg disease mapped with cortical thickness analysis.

Authors:  P Koskenkorva; E Niskanen; J Hyppönen; M Könönen; E Mervaala; H Soininen; R Kälviäinen; R Vanninen
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

4.  Coexistence of fixation-off sensitivity and inverted fixation-off sensitivity in a female child with Panayiotopoulos syndrome: Video-electroencephalography documentation.

Authors:  Imad Y Saadeldin; Hussein N Matlik
Journal:  Epilepsy Behav Case Rep       Date:  2015-05-28

5.  Neurophysiological and BOLD signal uncoupling of giant somatosensory evoked potentials in progressive myoclonic epilepsy: a case-series study.

Authors:  Silvia F Storti; Alessandra Del Felice; Laura Canafoglia; Emanuela Formaggio; Francesco Brigo; Franco Alessandrini; Luigi G Bongiovanni; Gloria Menegaz; Paolo Manganotti
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

6.  Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease.

Authors:  Saida Ortolano; Irene Vieitez; Roberto Carlos Agis-Balboa; Carlos Spuch
Journal:  Mol Brain       Date:  2014-01-28       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.